Abstract
Based on the structure of the thrombin--NAPAP complex, phosphinic dipeptide mimetics were designed as novel thrombin inhibitors. Synthesis and evaluation of these inhibitors revealed a promising lead with an IC50 of 0.6 microM.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antithrombins / chemistry*
-
Antithrombins / metabolism
-
Antithrombins / pharmacology*
-
Binding Sites
-
Computer Simulation
-
Dipeptides / chemistry
-
Dipeptides / metabolism
-
Drug Design
-
Inhibitory Concentration 50
-
Models, Molecular
-
Molecular Mimicry
-
Peptides / chemistry
-
Phosphinic Acids / chemistry*
-
Phosphinic Acids / metabolism
-
Phosphinic Acids / pharmacology*
-
Piperidines / chemistry
-
Piperidines / metabolism
-
Structure-Activity Relationship
-
Thrombin / chemistry
-
Thrombin / metabolism
Substances
-
Antithrombins
-
Dipeptides
-
Peptides
-
Phosphinic Acids
-
Piperidines
-
N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide
-
Thrombin